INGN
Inogen Inc
NASDAQ: INGN · HEALTHCARE · MEDICAL DEVICES
$7.26
+0.14% today
Updated 2026-10-29
Market cap
$186.83M
P/E ratio
—
P/S ratio
0.53x
EPS (TTM)
$-0.92
Dividend yield
—
52W range
$5 – $9
Volume
0.3M
Inogen Inc (INGN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.26
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$54.30
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -6.94%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.